NEW YORK STOCK EXCHANGE, INC. · ZBH
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Zimmer Biomet Holdings, Inc

Zimmer Biomet Holdings, Inc

Health Care
$87.47

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is ZBH moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Zimmer Biomet Holdings, Inc
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Listed since
2001
Employees
17K
Country
US

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$87.47
Last session
Day high
$87.47
Last session
Day low
$87.47
Last session
Previous close
$87.47
52W high
$87.47
0.00% from high
52W low
$87.47
Market cap
$16.9B
P/E
21.54×
EPS
$4.06
Shares out
193.5M
VWAP
$87.47
Last session
Veridion warehouse edge

Warehouse intelligence for ZBH.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

ZBH insider activity

Zimmer Biomet Holdings, Inc

Score
Coverage building
Pressure
Net selling
Filings
37
Buys / sells
0 / 37
Net value
-$7.9M
Insiders
8
Named filers
YS
Yi Sang
Insider
Leadership
NJ
Noor Jehanzeb
Insider
Leadership
WL
Winkler Lori
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net selling: -$7.9M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-06-022026-05-29Yi SangInsidersell$82.6680027,251$66KSEC Form 4
2026-06-022026-05-29Yi SangInsidersell$82.644,20028,051$347KSEC Form 4
2026-04-032026-04-01Noor JehanzebInsidersell$90.671,6775,151$152KSEC Form 4
2026-03-162026-03-12Winkler LoriInsidersell$94.662,65010,224$251KSEC Form 4
2026-03-102026-03-06VAN ZUILEN WILFREDInsidersell$92.5456230,991$52KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 32 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

ZBH contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ZBH in this window.
Lobbying spend

ZBH lobbying filings, year to date.

Registered lobbying filings matched to Zimmer Biomet Holdings, Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ZBH in this window.
Latest news · ZBH
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for ZBH.
Options
Sovereign unlock shows live options positioning for ZBH.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.